Convalescent Plasma for Treatment of COVID-19
Clinical trial NCT04649879 · COMPLETED
Trial details
- NCT number
- NCT04649879
- Sponsor
- Joakim Dillner
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-03
- Primary completion
- 2022-01-26
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.